Hubro Therapeutics AS
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Immune Response to FMPV-1 (NCT05238558) | Hubro Therapeutics AS | 2022-01-31 |
Track Hubro Therapeutics AS automatically
Every clearance here is in the API, with alerts when new ones post.